Loading...
Loading...
SGHT| Name | Value |
|---|---|
| Revenues | 20.2M |
| Cost of Revenue | 3.2M |
| Gross Profit | 16.9M |
| Operating Expense | 28.1M |
| Operating I/L | -11.2M |
| Other Income/Expense | 0.3M |
| Interest Income | 0.0M |
| Pretax | -10.9M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -11.1M |
Sight Sciences, Inc. is an ophthalmic medical device company specializing in surgical and nonsurgical technologies for eye disease treatment. Its flagship products include the OMNI Surgical System, designed to reduce intraocular pressure in adult glaucoma patients, and the TearCare System, a wearable eyelid technology for dry eye disease treatment. The company generates revenue by selling these products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States.
